-
eLife: Can sleep protect older people's memories?
Time of Update: 2020-08-28
may need to add sleep-like states to computers and robotic systems to prevent them from forgetting after new learning and to enable them to learn continuously, " says Bazhenov.
-
The researchers used meta-analysis to reveal hearing processing defects in dysfunction.
Time of Update: 2020-08-28
After analysis, the ineganic in agreement between the studies is mainly reflected in two aspects: first, whether DD's auditory processing defects are speech-specific or general; Recently, the Research Group of Bi Hongyan of the Institute of Psychology of the Chinese Academy of Sciences completed a meta-analysis aimed at quantitatively analyzing the existing literature, answering the above-mentioned controversial questions and clarifying the auditory processing characteristics of DD.
-
Irish scientists study how brain cells work to get new treatments for epilepsy.
Time of Update: 2020-08-28
Researchers at the National Centre for Chronic and Rare Neurological Diseases (FutureNeuro) of the Royal Irish Academy of Sciences, in collaboration with the Severo Ochoa Centre for Molecular Biology (CBMSO) in Madrid and the Institute of Biomedical Research (IRB) in Barcelona, have found key new steps in the functioning of human brain cells in the most common forms of epilepsy, potentially bringing new treatments to patients with drug-resistant epilepsy.
-
Alzheimer's (AD) overweight pounds! Yan Jian/Weiwood beta amyloid antibody aducanumab by the U.S. FDA priority review, accelerated approval!
Time of Update: 2020-08-27
If approved, aducanumab will be the first treatment that has the potential to meaningfully change the AD process and slow the decline of AD clinical conditions, and the first to demonstrate that removing beta amyloid (A beta) can achieve better clinical outcomes." AD is one of today's biggest public health challenges, resulting in patients gradually losing their memory and ability to live independently, ultimately depriving them of basic behavior.
-
Advances were made in the study of behavioral and olfactory neurodevelopment in male mice.
Time of Update: 2020-08-27
The study revealed the regulatory role of the micro-DNA 200-ketonic acid and iron ion-dependent bioxygenase 3 gene-neurogrowth inhibitor gene signaling axis in olfactory-mediated male mouse behavior and olfactory epidural neuron development.
-
J Psych Neurosci: Suffering from both anxiety disorders and depression may make the brain larger.
Time of Update: 2020-08-27
An important finding of this study is that many areas of the brain of individuals suffering from depression and anxiety shrink less, and even the size of the amygdala increases, suggesting that the true effects of depression on the brain may be underestimated by researchers because they have an opposite effect on the amygdala.
-
The neurobiological mechanism of bee population secretion of bee king pulp has been revealed.
Time of Update: 2020-08-27
Recently, the proteomics team of the Bee Research Institute of the Chinese Academy of Agricultural Sciences, based on the high-yielding bees of the bee king pulp selected in China, revealed the neurobiological basis for regulating the secretion of the bee king pulp through the study of brain-sniffing nerve leaves and mushroom proteomics.
-
Brain Commun: Relationship between intestinal disorders and Huntington's disease.
Time of Update: 2020-08-27
The study, led by Monash University's Turner Institute for Brain and Mental Health and in collaboration with the Flori Institute of Neuroscience, found evidence of intestinal malnutrition in people with HD, a change in bacteria in the gastrointestinal tract, and some disease-related intestinal symptoms.
-
For the first time, teams such as the Hong Kong National Congress have demonstrated that the new crown directly infects the human central system and that long-term consequences should be monitored.
Time of Update: 2020-08-27
results showed that the number of copies of the SARS-CoV-2 RdRp gene increased with the time of infection, suggesting that child virus particles were released from infected brain organs.
-
A new drug for narcolepsy! FDA grants strong anti-adrenaline reuptake inhibitor AXS-12 breakthrough drug eligibility!
Time of Update: 2020-08-27
Dr. Herriot Tabuteau, Ceo of Axsome, said, "The FDA's qualification of AXS-12 for the breakthrough drug for the treatment of sudden onset of sleeping sickness highlights the potential of the drug, if successfully developed, to bring meaningful benefits and substantial improvements to the patient population with this debilitating neurological disorder compared to current treatment options." we are excited about the rapid clinical advance of AXS-12, which has previously been granted orphan drugs to treat onset sleeping sickness.
-
Sci Rep: The researchers found predictive factors for the success of laser therapy in glacial eye patients.
Time of Update: 2020-08-27
, a new study from the University of Missouri School of Medicine and MU Health Care could reveal which patients might benefit from non-invasive treatments for selective laser beam forming (SLT).
-
Nature: New research on autism! Uncover the molecular mechanisms by which genetic mutations modify social behavior in people with autism!
Time of Update: 2020-08-27
August 9, 2020 // -- In a recent study published in the international journal Nature, scientists from the University of Basel and other institutions have found a new association between genetic change
-
Spinal muscular dystrophy (SMA) first oral medication! Roche Evrysdi has been approved for listing by the FDA and has submitted an application for listing in China!
Time of Update: 2020-08-27
!--ewebeditor:page title"--August 08, 2020 // -- Roche's GeneNek recently announced that the U.S. Food and Drug Administration (FDA) has approved Evrysdi (risdiplam) for the treatment of children and adults aged 2 months and older with spinal muscular dystrophy (SMA).
-
JNNP: New Discovery! Chinese scientists have discovered 10 risk factors for Alzheimer's disease!
Time of Update: 2020-08-27
August 8, 2020 // -- A few days ago, an article published in the international journal Journal of Neurology, Neurosurgery and Scientists from Fudan University and other institutions in China reported
-
CNS Neurosci Ther: Brain cells communicate with each other during a stroke.
Time of Update: 2020-08-27
these findings provide important advances in the broad correlation between neuron cell survival, brain function, especially stroke and neurodegenerative diseases.
(bioon.com) Source: Research unlocks key mechanism in the communications between brain cells during stroke Original source: Belayev, L., et al.
-
EMBO J: New research could help treat Huntington's disease.
Time of Update: 2020-08-27
7, 2020 /--- -- In a recent study, scientists discovered that an enzyme called TBK1 plays a central role in regulating the degradation and removal of Huntington's protein.
-
JAMA: Nearly 20,000 people have shown that vitamin D intake does not seem to reduce the risk of depression in adults!
Time of Update: 2020-08-27
August 9, 2020 // -- In a recent study published in jama, an international journal, scientists from Massachusetts General Hospital and other institutions conducted the largest study of its kind to dat
-
What should I do when anxiety affects sleep?
Time of Update: 2020-08-26
caffeine may affect sleep.
caffeine can also affect sleep quality.
try the following techniques to make your sleep better: First, create the ideal sleep environment.
computer screens or other electronic devices between half an hour and an hour before bed.
-
Painkillers! FDA approves o tablet agonist Olinvyk, which works for 2-5 minutes and lasts 3 hours, more effective than morphine!
Time of Update: 2020-08-26
Olinvyk is an acute pain treatment drug developed by Trevena for short-term intravenous use in hospitals or other controlled clinical settings, such as inpatient and outpatient procedures.
-
The Lancet: Do 12 well to prevent 40% dementia.
Time of Update: 2020-08-26
There is growing evidence to support the Nine potential modifiable risk factors modeled by the Lancet Commission for dementia prevention, intervention and care in 2017, including low levels of education, high blood pressure, hearing impairment, smoking, obesity, depression, lack of exercise, diabetes and low social exposure.
